Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 34 (25) 3047-3053
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
Yes
Book Volume:
6
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
GI    
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA189823, U10 CA077202, U10 CA180821, U10 CA180850, U10 CA180882, U24 CA196171, U10 CA180820, U10 CA180867, U10 CA180838, U10 CA180888  
Corr. Author:
 
Authors:
                                       
Networks:
CA824, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NH012, LAPS-OH007, MI005   
Study
CALGB-150705
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-9581
Phases:
N/A, 3
Keywords:
Gic7, To4, To15, ORIGINAL REPORTS, Gastrointestinal Cancer